341: NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers
The Readout Loud
Intro
This chapter examines recent NIH funding cuts and their potential effects on biomedical innovation in the U.S. It also delves into the skepticism surrounding drug companies' claims about using artificial intelligence for drug discovery amid these financial challenges.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
